Although individual responses vary, the consistency of findings strengthens the case for a modest hypertension benefit associated with GLP-1 therapy
Confirm the final total at checkout before completing the order
doi: 10.1016/j.peptides.2024.171212 Summary Keywords GIP -glucose-dependent insulinotropic polypeptide, antagonism, obesity, diabetes, pharmacology Citation Koefoed-Hansen F, Helsted MM, Kizilkaya HS, Lund AB, Rosenkilde MM and Gasbjerg LS (2025) The evolution of the therapeutic concept GIP receptor antagonism
Acta Paediatr Jpn 40:2629 van Es A, Henny FC, Kooistra MP et al (1992) Amelioration of cardiac function by L-carnitine administration in patients on haemodialysis
#MetabolicHealth #Obesity #Type2Diabetes #Metabolism #InsulinResistance #Research To view or add a comment, sign in One of the most important concepts in hormone optimization is also one of the most frequently overlooked: Total testosterone and free testosterone are not the same thing